Articles On Avita Medical (ASX:AVH)

The ASX Emerging Companies index (XEC) ran free on Tuesday, climbing over 3%, apparently unrestrained by the various macro or geopolitical issues bothering the rest of us. That said, the more gown up ASX200 also lifted on Tuesday, gaining a...

Skin regeneration specialist Avita Medical (AVH) bolsters revenue and shrinks its net loss for the six months to the end of December 2021 The company says over this time period, it grew revenue by 37 per cent to US$14 million (A$19 million...

The Avita Medical Inc (ASX: AVH) share price is skyrocketing today after the company released its financial results for a six month “transition period” ended 31 December 2021. The company announced in December 2021 that it wanted to change...

The ASX 200 Health Index (XHJ) is trading higher by 0.55% at the time of writing, compared to the broader index which is up by 0.45%. Cannabis stock Avecho Biotechnology (ASX:AVE) announced today that patient dosing has commenced for its Ph...

Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly for a year. The ETF peaked at US$112.23 on the 8th of February 2021, and is down 60% to US$45.99.   Source: Yahoo FinanceHea...

ShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valuations is creating rare buying opportunities as investors flee ‘riskier’ sectors on the back of rising interest rates, dwindling liquidity a...

In this week’s video insight Joseph discusses the key drivers of The Montgomery Fund’s performance for calendar year 2021. Overall, 2021 was a successful year for The Montgomery Fund. The total return of 25.1 per cent after fees represented...

Regenerative medicine company AVITA Medical (ASX:AVH) has completed enrollment in its pivotal trial for the use of the RECELL System for soft tissue reconstruction.

The Montgomery Fund (The Fund) closed an impressive 2021, outperforming the S&P/ASX 300 Accumulation Index by 7.61 per cent, after fees. Over the year The Fund also paid a solid distribution at 30 June and a smaller one at 31 December,...

The AVITA Medical Inc (ASX: AVH) share price is pushing higher on Tuesday morning. In morning trade, the regenerative medicine company’s shares are up 3.5% to $3.25. Why is the AVITA share price pushing higher? Investors have been bidding...

AVITA Medical Inc. (AVH) releases preliminary unaudited estimates of its top line results for its latest financial quarter AVITA’s total revenue increased 35 per cent to US$6.9 million, compared to US$5.1 million over the same quarter last...

Selling pressure eases on Wall Street After the big tumble on Wednesday following the release of Fed’s rate cut plans, US stocks fell more modestly overnight. All three major benchmarks were down – the S&P 500 by 0.10%, the Dow by 0.47%...

AVITA Medical (AVH) reports its preclinical data establishes proof of concept in two key areas of cell-based gene therapy – skin rejuvenation and epidermolysis bullosa Data shows successful regeneration of the skin when AVITA’s Spray-On Sk...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

The AVITA Medical Inc (ASX: AVH) share price has dropped to a 52-week low today despite news that the medical producer has entered its RECELL System product into a trial. Today’s slide comes off the back of a 2.78% fall yesterday after th...

Shares in regenerative medicine group Avita Medical Inc (ASX: AVH) are in the red today, down 2.78% to $3.50. This means the Avita share price is now down 22.08% over the past month. Today’s falling share price comes amid an announcement...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

It’s now been two-and-a-half years since US tech stock Life360 (ASX:360) listed on the ASX at $4.79 a share and it now sits at $13.51. The company’s flagship product is a smartphone app that provides information such as where families membe...

It was a disappointing day for the Avita Medical Inc (ASX: AVH) share price as it hit a new 2-year low. The regenerative medicine company has failed to regain momentum since the beginning of its fall from grace during the COVID-19 crash....

The ASX closed down again today in spite of resources and tech gaining over 1%. The ASX 200 fell 0.24%, closing at 7,434 points. Despite the gains in resources and tech most other sectors fell with financials, property and energy retreating...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has dropped back into the red. At the time of writing, the benchmark index is down 0.15% to 7,442.1 points. Four ASX shares that are falling more than most today are listed below. He...

The Avita Medical Inc (ASX: AVH) share price is sliding well into the red in afternoon trading and is now down 10.98% at $4.54. It comes following the release of the company’s earnings report for the three months ended 30 September 2021....

AVITA Medical (AVH) raked in $7 million in revenue during the first quarter, representing a 39 per cent increase year-on-year The healthcare stock released its quarterly results on Tuesday, revealing its gross profit margin increased from...

The ASX 200 Health Index (XHJ) is up by 0.57% at the time of writing, compared to the broader index which is up by 0.03%. The US FDA has cleared Pharmaxis (ASX:PXS)’s Investigational New Drug application (IND) for a trial of its lead drug,...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these...

Today was a great day on the ASX for the Avita Medical Inc (ASX: AVH) share price. The medical technology company’s stock was boosted by news that the US authority Centers for Medicare and Medicaid Services has approved Avita’s application...

The ASX rose 0.48% today to reach its highest point in the week. While energy lost 2% most other sectors were in the green with tech and financials gaining over 1%. Today’s gains came despite the Federal Reserve unveiling a tapering of stim...

The AVITA Medical Inc (ASX: AVH) share price will be keenly watched when the ASX opens on Thursday after some big news overnight pushed its US shares up 7%. The company provides regenerative medical technology, with its ReCell spray-on ski...

ASX-listed mobile health (mHealth) company Advanced Human Imaging (AHI) is moving forward with its planned dual-listing on the NASDAQ exchange Listing on the NASDAQ will place Advanced Human Imaging on one of the highest-quality and highes...

The AVITA Medical Inc (ASX: AVH) share price is climbing higher this morning following the release of the company’s financial year 2021 (FY21) earnings. at the time of writing, the AVITA share price is up 7.13%, trading at $5.335. AVITA Me...

Highlights AVITA Medical disclosed that the US Food and Drug Administration (FDA) has authorised its request to amend the RECELL® System pivotal trial. Pharmaxis has granted Aptar Pharma an exclusive 12-month option for developing and...

The Avita Medical Inc (ASX: AVH) share price is in the green in early afternoon trade. Avita shares are on the move after the company gained regulatory momentum overnight. Let’s discuss further. A quick refresher on Avita Medical Avita...

Melbourne-based medtech company Avita Medical (ASX: AVH) has received US Food and Drug Administration (FDA) approval to amend its clinical trial for the treatment of vitiligo patients, giving hope to the millions that suffer from the rare s...

Global markets stay cool US stocks edged higher overnight to post their fifth straight day of gains, as attention centred around geo-political concerns following the US withdrawal from Afghanistan. The Dow Jones rose by 0.31%, and the S&am...

In Short & Caught, Stockhead recaps the ASX stocks that are the most shorted right now.   How does shorting work? Shorting works by selling stocks you do not actually own in the hope of buying them back at a lower price. Investors are i...

Buy ASX shares for the long term, we’re always told. Don’t try to time the market. But the irony is the same experts that espouse this to retail investors don’t, or can’t, follow it themselves. That’s because fund managers are judged by po...

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, The Montgomery Fund portfolio manager Joseph Kim reveals a pair of ASX shares that he’d be intrig...

Whether you take a contrarian view to investing or like to hop on what’s hot, it’s interesting to see which ASX sectors have fared the best in the past year. Perhaps you want to put some money into the sectors that haven’t gone so well, th...

One much-hyped ASX share has given little joy to investors over the last 12 months. But The Montgomery Fund portfolio manager Joseph Kim has told holders of the healthcare stock to be patient, as the numbers still look pretty good. Regener...

Wall Street takes record highs even higher All three US benchmarks rose overnight, as American consumer confidence for April rose the highest since the pandemic began and US house prices jumping the most in three decades. The Dow Jones and...

If you are a longer-term shareholder of Avita Medical (ASX:AVH), it is likely you would have experienced a rather disappointing journey over the past 12 months. COVID-19 and lockdowns in the US have stymied the RECELL roll-out just as it wa...

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

While small cap ASX share carry more risk than their larger rivals, the potential returns on offer makes it worth considering including one or two in a balanced portfolio if your risk profile allows. But which small cap shares should you b...

ShareCafeThe Week that Was – June 14-18, 2021 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so, h...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

The S&P/ASX 200 (ASX: XJO) finished at another record, adding 0.1% on Wednesday despite weakening throughout the day. Most sectors finished higher, led by the energy sector, up 1.5%, with the materials and IT down 1.6% and 0.4%, respect...

ShareCafeAvita Medical Gives Shareholders a Lift Investors loved yesterday’s June quarter update from dual-listed skin repair biotech Avita Medical . The company raised its quarterly guidance due to the strength of orders for its flagship t...

Summary Commonwealth Bank (ASX:CBA) sets new high, adds nearly A$7 billion in value over 3 weeks Orthocell (ASX:OCC) gets patents for suture-less repair of soft tissue AF Legal Group (ASX:AFL) completes Watts McCray acquisition...

The S&P/ASX 200 Index (ASX: XJO) rose 0.1% to 7,386 points. Here are some of the highlights from the ASX today: AVITA Medical Inc (ASX: AVH) The Avita share price went up over 12% in reaction to an update about its FY21 fourth quarte...